Ildong Pharmaceutical company had a signing ceremony with AstraZeneca Korea for the co-promotion of the type 2 diabetes treatment

Published: 2014-03-07 15:06:23

Updated: 2014-03-07 15:08:51

On Mar 4, Ildong Pharmaceutical company had a signing ceremony with AstraZeneca Korea for the co-promotion of the type 2 diabetes treatment Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin complexe with extended release).

Starting from March, both companies will carry out sales and marketing activity of the product in general hospitals, and Ildong alone will carry out sales...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.